These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7183523)

  • 1. Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy.
    Eskandari H; Ablin RJ; Bhatti RA
    Indian J Exp Biol; 1982 Dec; 20(12):872-4. PubMed ID: 7183523
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic studies of prostatic cancer using the R3327 rat model.
    Lubaroff DM; Reynolds CW; Culp DA
    Trans Am Assoc Genitourin Surg; 1978; 70():60-5. PubMed ID: 753024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
    Lindström P; Bergh A; Holm I; Damber JE
    Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulation by cryosurgery: an orthotopic model of prostate and bladder cancer in the rat.
    Bonney WW; Henstorf JE; Emaus SP; Lubaroff DM; Feldbush TL
    Natl Cancer Inst Monogr; 1978 Dec; (49):375-81. PubMed ID: 748797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryosurgical ablation of the normal ventral prostate plus adjuvant does not protect Copenhagen rats from Dunning prostatic adenocarcinoma challenge.
    Friedman EJ; Orth CR; Brewton KA; Ponniah S; Alexander RB
    J Urol; 1997 Oct; 158(4):1585-8. PubMed ID: 9302178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.
    Isaacs JT; Coffey DS
    Cancer Res; 1981 Dec; 41(12 Pt 1):5070-5. PubMed ID: 7307008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity following double freezing of the prostate of patients with prostatic cancer.
    Ueda K; Ohtaguro K; Washida H; Jinno H; Fushimi N; Masegi T
    Prog Clin Biol Res; 1982; 107():815-26. PubMed ID: 7167530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryosurgery of SV40 prostatic transplant tumors: tumor control, biochemical correlates and immunity.
    Neel HB; Ketcham AS; Hammond WG
    Int Surg; 1972 Jan; 57(1):61-6. PubMed ID: 4333505
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma.
    Landström M; Bergh A; Tomic R; Damber JE
    Prostate; 1990; 17(1):57-68. PubMed ID: 1696714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic aspects of the prostate.
    Lubaroff DM; Reynolds CW; Canfield L; McElligott D; Feldbush T
    Prostate; 1981; 2(3):233-48. PubMed ID: 6170966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dunning R3327 prostate adenocarcinoma in the Fischer-Copenhagen F1 rat: a useful model for immunological studies.
    Claflin AJ; McKinney EC; Fletcher MA
    Oncology; 1977; 34(3):105-9. PubMed ID: 917439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A
    Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cryo-immunological response in prostatic cancer].
    Martínez-Piñeiro JA; Ruíz F; Hidalgo L; Muntañola P
    Actas Urol Esp; 1978; 2(1):23-32. PubMed ID: 665346
    [No Abstract]   [Full Text] [Related]  

  • 15. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
    Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
    Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine manipulation of the Dunning prostatic adenocarcinoma.
    Shessel FS; Block NL; Stover B; Claflin A; Malinin TI; Politano VA
    Invest Urol; 1980 May; 17(6):529-33. PubMed ID: 7372443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination effect of flutamide and leuprorelin acetate on growth of Dunning R3327-H prostatic adenocarcinoma in rats].
    Tomura A; Kuroiwa S; Okada M; Abe F
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):563-9. PubMed ID: 9530363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in host responsiveness in patients with prostatic cancer following cryosurgery or transurethral resection.
    Ablin RJ; Bruns GR; Guinan PD; Sadoughi N; Sheik HA; Bush IM
    Am Surg; 1977 Mar; 43(3):144-50. PubMed ID: 320926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma.
    Granfors T; Damber JE; Bergh A; Landström M; Löfroth PO; Widmark A
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1031-6. PubMed ID: 9392541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological surveillance and -globulin.
    Ablin RJ
    Isr J Med Sci; 1973 Apr; 9(4):480-3. PubMed ID: 4122703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.